Drug-induced upper gastrointestinal disorders requiring hospitalization: A five-year study in a South Indian hospital

Pharmacoepidemiology and Drug Safety

Volumn 13, Issue 12, 2004, Pages 859-862

  Devi, D Padmini ^a   Sushma, M ^a   Guido, S ^a  

^a ST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES   (India)

Author keywords

Adverse drug reactions; Aspirin; Gastric erosion; GIT disorders; NSAIDs

Indexed keywords

ACETYLSALICYLIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; CEFADROXIL; CIPROFLOXACIN; DICLOFENAC; ERYTHROMYCIN; ETHAMBUTOL; IBUPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; STEROID;

ABDOMINAL PAIN; ADULT; ALCOHOL CONSUMPTION; ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DRUG INDUCED DISEASE; DRUG USE; DUODENUM ULCER; DYSPEPSIA; ENDOSCOPY; EPIGASTRIC BURNING; FEMALE; GASTROINTESTINAL DISEASE; HEMATEMESIS; HOSPITAL DEPARTMENT; HOSPITALIZATION; HUMAN; INDIA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MELENA; NAUSEA AND VOMITING; PEPTIC ULCER; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SMOKING; STOMACH EROSION; STOMACH ULCER;

ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; DUODENAL ULCER; FEMALE; GASTROINTESTINAL DISEASES; HOSPITALIZATION; HUMANS; INDIA; MALE; MIDDLE AGED; PHARMACEUTICAL PREPARATIONS; RETROSPECTIVE STUDIES; RISK FACTORS; STEROIDS; STOMACH ULCER;

EID: 10844225336     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/pds.988     Document Type: Article

References (12)

1. Ramesh M, Pandit J, Parthasarathy G. Adverse drug reactions in a South Indian hospital - their severity and cost involved. Pharmacoepidemiol Drug Safe (published online 16 July 2003; pp. 687-692: website http://www3.interscience.wiley.com.)
2. Mac Donald TM, Morant SV, Robinson GC. Association of upper gastrointestinal toxicity of non-steroidal anti-inflammatory drugs with continued exposure: cohort study. Br Med J 1997; 315: 1333-1337.
3. Delamothe T. Reporting adverse drug reactions. Br Med J 1992; 304: 465.
4. World Health Organization. Technical report series 498. World Health Geneva, 1972.
5. McCarthy D. Non-steroidal and inflammatory drug-related gastrointestinal toxicity: definitions and epidemiology. Am J Med 1998; 105(5A): 3s-9s.
6. Hoogerwer WA, Pasricha P. Agents used for control of gastric acidity and treatment of peptic ulcers and gastroesophageal reflex disease. In Goodman and Gilman's The Pharmacological Basis of Therapeutics, Hardman JG, Limbred LE, Gilman AG (eds). The McGraw Hill Companies: United States of America, 2001; 1017.
7. Gabriel SE, Jaakkimainen L, Bombardier C. Risk for serious gastrointestinal complications related use of nonsteroidal anti inflammatory drugs: a meta-analysis. Ann Internal Med 1991; 115 787-796.
8. Wallace JL. Non-steroidal anti inflammatory drugs and gastrentropathy: the second hundred years. Gastroentrology 1997; 112: 1000-1016.
9. Cryer B. Non-steroidal anti-inflammatory drug injury. In Sleisenger and Fordtran's Gastrointestinal and Liver Diseases, Pathophysiology/Diagnosis/Management (Vol. 1), Feldman M, Friedman LS, Sleisenger M (eds). Elsevier Science: United States of America, 2002; 416.
10. Chambers HF. Cloramphenicol, tetracyclines, macrolides, clindamycin and streptogramins. In Basic and Clinical Pharmacology, Katzung BG (ed.). McGraw Hill Companies: United States, 2001; 780.
11. Marshall WF, Blair JE. The Cephalosporins. Mayo Clin Proc 1999; 74: 187-195.
12. Lanas A, Bajador E, Serrano P, Fuentes J. Nitro vasodilators, low dose aspirin, other nonsteroidal anti-inflammatory drugs and the risk of upper gastrointestinal bleeding. New Engl J Med 2000; 343: 834-839.